2016 Blood Cancer Patients Conference on Treatment Options

Treatment Options for Blood Cancer Patients Conference

Presentation slides, audio and video below from the May 21, 2016 Conference.

Click the red text to access slides, audio or video.

BMT Update: Haplo-identical Transplant
Dr. Zeina Al-Mansour
Loyola University Medical Center

Presentation Slides
Audio
Video

Multiple Myeloma - Is It Now a Curable Disease?
Dr. Pritesh Patel,
University of Illinois Chicago Medical Center
Presentation Slides
Audio
Video

New Approaches for Transplant Patients
Dr. Linda Burns,
National Marrow Donor Program/Be The Match
Presentation Slides
Audio
Video

Treatment Approaches for Low Grade Lymphomas
Dr. Parameswaran Venugopal,
Rush University Medical Center
Presentation Slides
Audio
Video

The Increasing Use of Targeted Therapies
for Leukemia and Lymphoma

Dr. Shira Dinner,
Robert H. Lurie Comprehensive Cancer Center
of Northwestern University

Presentation Slides
Audio
Video

Evolving Therapies for Elderly Patients with Blood Cancers
Dr. Andrew Artz,
University of Chicago Hospitals
Presentation Slides
Audio
Video

CART T-Cells: New Effective Therapy
for Leukemia and Lymphoma

Dr. Patrick Stiff,
Loyola University Medical Center
Presentation Slides
Audio
Video

Physician Panel: Ask the Experts Q & A

What are the benefits of clinical trials?
Dr. Patrick Stiff,
Loyola University Medical Center
Dr. Linda Burns,
National Marrow Donor Program/Be The Match

When would it be appropriate for a multiple myeloma patient to have an allogeneic transplant?
Dr. Pritesh Patel,
University of Illinois Chicago Medical Center

If you had CLL, 17P deletion and un-mutated and never treated, and had to start treatment now, what would you choose to do?
Dr. Parameswaran Venugopal,
Rush University Medical Center
Dr. Andrew Artz,
University of Chicago Hospitals

What makes a clinical trial successful, especially in multiple myeloma?
Dr. Linda Burns,
National Marrow Donor Program/Be The Match
Dr. Patrick Stiff,
Loyola University Medical Center

How can a transplant be done on an outpatient basis when the patient is stripped of an immune system?
Dr. Linda Burns,
National Marrow Donor Program/Be The Match
Dr. Zeina Al-Mansour,
Loyola University Medical Center

What do you do as a patient when you have two opinions about treatment that conflict?
Dr. Patrick Stiff,
Loyola University Medical Center
Dr. Andrew Artz,
University of Chicago Hospitals

Please discuss AML briefly.
Dr. Andrew Artz,
University of Chicago Hospitals
Dr. Patrick Stiff,
Loyola University Medical Center
Dr. Linda Burns,
National Marrow Donor Program/Be The Match

Why does it seem like patients are given the maximum dose of a chemotherapy drug, rather than working up from a smaller dose?
Dr. Parameswaran Venugopal,
Rush University Medical Center
Dr. Patrick Stiff,
Loyola University Medical Center

Is MDS hereditary? Can medications taken for other disorders cause MDS?
Dr. Andrew Artz,
University of Chicago Hospitals
Dr. Shira Dinner,
Robert H. Lurie Comprehensive Cancer Center of Northwestern University